Difference between revisions of "Part:BBa K404120"
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K404120 short</partinfo> | <partinfo>BBa_K404120 short</partinfo> | ||
+ | <br><br><br> | ||
+ | {| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right" | ||
+ | ! colspan="2" style="background:#66bbff;"|[https://parts.igem.org/Part:BBa_K404120 [AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR ] | ||
+ | |- | ||
+ | ! colspan="2"|[[Image:Freiburg10_Vectorplasmid composite 2.png|300px]] | ||
+ | |- | ||
+ | |'''BioBrick Nr.''' | ||
+ | |[https://parts.igem.org/Part:BBa_K404120 BBa_K404120] | ||
+ | |- | ||
+ | |'''RFC standard''' | ||
+ | |[https://parts.igem.org/Help:Assembly_standard_10 RFC 10]<br/> | ||
+ | |- | ||
+ | |'''Requirement''' | ||
+ | |pSB1C3<br> | ||
+ | |- | ||
+ | |'''Source''' | ||
+ | |pAAV_MCS provided by Stratagene | ||
+ | |- | ||
+ | |'''Submitted by''' | ||
+ | |[http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010] | ||
+ | |} | ||
+ | <br> | ||
+ | |||
+ | [[Image:Freiburg10_Vectorplasmid composite 2.png|left|thumb|480px]]<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
+ | |||
+ | <html> | ||
+ | <head> | ||
+ | <meta http-equiv="Content-Type" | ||
+ | content="text/html; charset=windows-1252"> | ||
+ | <meta name="Generator" | ||
+ | content="Microsoft Word 14 (filtered)"> | ||
+ | <style> | ||
+ | <!-- | ||
+ | /* Font Definitions */ | ||
+ | @font-face | ||
+ | {font-family:Calibri; | ||
+ | panose-1:2 15 5 2 2 2 4 3 2 4;} | ||
+ | /* Style Definitions */ | ||
+ | p.MsoNormal, li.MsoNormal, div.MsoNormal | ||
+ | {margin-top:0cm; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:10.0pt; | ||
+ | margin-left:0cm; | ||
+ | line-height:115%; | ||
+ | font-size:11.0pt; | ||
+ | font-family:"Calibri","sans-serif";} | ||
+ | h1 | ||
+ | {mso-style-link:"Heading 1 Char"; | ||
+ | margin-top:24.0pt; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:0cm; | ||
+ | margin-left:0cm; | ||
+ | margin-bottom:.0001pt; | ||
+ | line-height:115%; | ||
+ | page-break-after:avoid; | ||
+ | font-size:14.0pt; | ||
+ | font-family:"Cambria","serif"; | ||
+ | color:red;} | ||
+ | p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph | ||
+ | {margin-top:0cm; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:10.0pt; | ||
+ | margin-left:36.0pt; | ||
+ | line-height:115%; | ||
+ | font-size:11.0pt; | ||
+ | font-family:"Calibri","sans-serif";} | ||
+ | p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst | ||
+ | {margin-top:0cm; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:0cm; | ||
+ | margin-left:36.0pt; | ||
+ | margin-bottom:.0001pt; | ||
+ | line-height:115%; | ||
+ | font-size:11.0pt; | ||
+ | font-family:"Calibri","sans-serif";} | ||
+ | p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle | ||
+ | {margin-top:0cm; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:0cm; | ||
+ | margin-left:36.0pt; | ||
+ | margin-bottom:.0001pt; | ||
+ | line-height:115%; | ||
+ | font-size:11.0pt; | ||
+ | font-family:"Calibri","sans-serif";} | ||
+ | p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast | ||
+ | {margin-top:0cm; | ||
+ | margin-right:0cm; | ||
+ | margin-bottom:10.0pt; | ||
+ | margin-left:36.0pt; | ||
+ | line-height:115%; | ||
+ | font-size:11.0pt; | ||
+ | font-family:"Calibri","sans-serif";} | ||
+ | span.Heading1Char | ||
+ | {mso-style-name:"Heading 1 Char"; | ||
+ | mso-style-link:"Heading 1"; | ||
+ | font-family:"Cambria","serif"; | ||
+ | color:red; | ||
+ | font-weight:bold;} | ||
+ | .MsoChpDefault | ||
+ | {font-family:"Calibri","sans-serif";} | ||
+ | .MsoPapDefault | ||
+ | {margin-bottom:10.0pt; | ||
+ | line-height:115%;} | ||
+ | @page WordSection1 | ||
+ | {size:612.0pt 792.0pt; | ||
+ | margin:70.85pt 70.85pt 2.0cm 70.85pt;} | ||
+ | div.WordSection1 | ||
+ | {page:WordSection1;} | ||
+ | --> | ||
+ | </style> | ||
+ | </head> | ||
+ | <body lang="EN-US"> | ||
+ | <div class="WordSection1"> | ||
+ | <p class="MsoNormal" style="text-align: justify;"><span | ||
+ | style="font-size: 10pt; line-height: 115%;">Producing | ||
+ | recombinant virus particles for therapeutical | ||
+ | applications is, besides specific cell targeting, purification and | ||
+ | quantification assays of AAV-2, one intention of the Virus Construction | ||
+ | Kit | ||
+ | provided by the iGEM team Freiburg_Bioware 2010. For obtaining a | ||
+ | modular | ||
+ | toolkit, the complex biological system of the Adeno-associated virus | ||
+ | serotype 2 | ||
+ | was examined by an exhaustive literature search. Subsequently, the | ||
+ | essential | ||
+ | components for AAV-2 particle production were extracted and redesigned | ||
+ | to match | ||
+ | the iGEM standard.</span></p> | ||
+ | <p class="MsoNormal" style="text-align: justify;"><span | ||
+ | style="font-size: 10pt; line-height: 115%;">The provided | ||
+ | tripartite system is independent of a | ||
+ | superinfection of Adeno- or herpes simplex viruses since the | ||
+ | genes encoding | ||
+ | the required helper-proteins are co-transfected. Inside the eukaryotic | ||
+ | host | ||
+ | cell, the DNA sequence containing the inverted terminal repeats (ITRs) | ||
+ | is | ||
+ | extracted and later encapsidated into the preformed capsids after | ||
+ | production of | ||
+ | single-stranded DNA. Consequently, this plasmid is known as the vector | ||
+ | plasmid | ||
+ | (pGOI). Promoter, <i>beta-globin</i> intron and the hGH | ||
+ | terminator signal are | ||
+ | flanked by the ITRs (ITRs, BBa_K404100 and BBa_K404101) and regulate | ||
+ | transgene | ||
+ | expression. The vector plasmid containing the desired gene of interest | ||
+ | is | ||
+ | cotransfected with the RepCap plasmid (BBa_K404001, BBa_K404002 or | ||
+ | BBa_K404003) | ||
+ | and the pHelper plasmid. To obtain the fully assembled vector plasmid, | ||
+ | several | ||
+ | assembly steps have to be performed. </span></p> | ||
+ | <p class="MsoNormal" style="text-align: justify;"><span | ||
+ | style="font-size: 10pt; line-height: 115%;">The Composite | ||
+ | part </span><span style="font-size: 10pt; line-height: 115%;">[AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR | ||
+ | provided by the iGEM team Freiburg_Bioware comprises all <i>cis</i>-elements | ||
+ | required for efficient transgene expression in mammalian cells | ||
+ | (polyadenylation | ||
+ | terminator: </span><span | ||
+ | style="font-size: 10pt; line-height: 115%;">BBa_K404108 </span><span | ||
+ | style="font-size: 10pt; line-height: 115%;">and | ||
+ | transcription enhancer element: </span><span | ||
+ | style="font-size: 10pt; line-height: 115%;">BBa_K404107)</span><span | ||
+ | style="font-size: 10pt; line-height: 115%;"> and | ||
+ | encapsidation into virus | ||
+ | particles (</span><span | ||
+ | style="font-size: 10pt; line-height: 115%;">ITRs: | ||
+ | BBa_K404100 and BBa_K404101). The CFP coding sequence as gene of | ||
+ | interest enables | ||
+ | facile detection of transduced cells using flow cytometry or | ||
+ | fluorescence | ||
+ | microscopy.</span></p> | ||
+ | <p class="MsoNormal"> </p> | ||
+ | </div> | ||
+ | </body> | ||
+ | </html> | ||
+ | |||
− | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 12:44, 31 October 2010
[AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR
[AAV2-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR ] | |
---|---|
BioBrick Nr. | BBa_K404120 |
RFC standard | RFC 10 |
Requirement | pSB1C3 |
Source | pAAV_MCS provided by Stratagene |
Submitted by | [http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010] |
Producing recombinant virus particles for therapeutical applications is, besides specific cell targeting, purification and quantification assays of AAV-2, one intention of the Virus Construction Kit provided by the iGEM team Freiburg_Bioware 2010. For obtaining a modular toolkit, the complex biological system of the Adeno-associated virus serotype 2 was examined by an exhaustive literature search. Subsequently, the essential components for AAV-2 particle production were extracted and redesigned to match the iGEM standard.
The provided tripartite system is independent of a superinfection of Adeno- or herpes simplex viruses since the genes encoding the required helper-proteins are co-transfected. Inside the eukaryotic host cell, the DNA sequence containing the inverted terminal repeats (ITRs) is extracted and later encapsidated into the preformed capsids after production of single-stranded DNA. Consequently, this plasmid is known as the vector plasmid (pGOI). Promoter, beta-globin intron and the hGH terminator signal are flanked by the ITRs (ITRs, BBa_K404100 and BBa_K404101) and regulate transgene expression. The vector plasmid containing the desired gene of interest is cotransfected with the RepCap plasmid (BBa_K404001, BBa_K404002 or BBa_K404003) and the pHelper plasmid. To obtain the fully assembled vector plasmid, several assembly steps have to be performed.
The Composite part [AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR provided by the iGEM team Freiburg_Bioware comprises all cis-elements required for efficient transgene expression in mammalian cells (polyadenylation terminator: BBa_K404108 and transcription enhancer element: BBa_K404107) and encapsidation into virus particles (ITRs: BBa_K404100 and BBa_K404101). The CFP coding sequence as gene of interest enables facile detection of transduced cells using flow cytometry or fluorescence microscopy.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 1319
Illegal AgeI site found at 2039 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 2441